Comparative-Effectiveness Study Confirms New Treatment for Diabetic Macular Edema – 3
Narrator: This is NIH Health Matters. I’m Joe Balintfy. For an eye condition called diabetic macular edema, a laser treatment has been the standard care for the past 25 years. But Dr. Neil Bressler from the Wilmer Eye Institute, at Johns Hopkins University explains new research is showing better vision than laser treatment alone.
Bressler: The new treatment option now is to use a new drug, which is called Ranibizumab, or the trade name is Lucentis, and by injecting that as often as every four weeks for at least one to two years, we found that you could get improvement in vision about 50 percent of the time.
Balintfy: For more about Diabetic Macular Edema research and treatment options, visit www.nei.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.